Journal
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
Volume 88, Issue 2, Pages -Publisher
WILEY
DOI: 10.1111/aji.13580
Keywords
inflammation; metabolites; microbial-mediated therapy; microbiota; PCOS
Categories
Ask authors/readers for more resources
PCOS is a complex disease that may be caused by a combination of environmental and genetic factors. Recent research suggests a link between gut microbiota and the emergence of the syndrome. By modulating gut microbiota, metabolic, inflammatory, and hormonal profiles in PCOS women can be improved.
Polycystic ovarian syndrome (PCOS) is a complicated neuro-endocrinal, reproductive, and metabolic condition. It encompasses patterns such as hyperandrogenism, recurrent cysts triggered by steroidogenic functional aberrations in the ovaries, overweight, chronic inflammation, and more. The underlying cause of this heterogeneous illness is obscure, although it is suspected to be driven by a blend of environmental and hereditary factors. In recent years, the connection between the microbiome and PCOS has been acknowledged and is thought to be involved in the genesis of the syndrome's emergence. Microbiota vary in different pathological features of PCOS, and fundamental pathways linked to their involvement in the commencement of diverse clinical presentations in PCOS open up a new avenue for its management. Prebiotic, probiotic, synbiotic, and fecal-microbiota-transplant, by promoting eubiosis and nullifying the effect caused by the altered microbial profile in PCOS women, can aid in management of diverse phenotypes associated with the syndrome. These microbiota-mediated treatments improve PCOS women's metabolic, inflammatory, and hormonal profiles. However, more studies are needed to elucidate the mechanisms that drive this positive effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available